Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

8. BIOLOGICAL ASSETS: Schedule of assumptions used in valuation of Fair value of biological assets (Details)

v3.21.2
8. BIOLOGICAL ASSETS: Schedule of assumptions used in valuation of Fair value of biological assets (Details)
12 Months Ended
Dec. 31, 2020
CAD ($)
Details  
Weighted Average Assumption, Selling Price $0.19
Monetary amounbt, 10% change od input - Selling Price $ 1,211,741
Weighted Average Assumption, Yield by plant 71.41
Monetary amounbt, 10% change od input - Yield by plant $ 1,147,615
Weighted Average Assumption, Attrition 5.52%
Monetary amounbt, 10% change od input - Attrition $ 70,859
Weighted Average Assumption, Postharvest costs ($/gram) $0.01
Monetary amounbt, 10% change od input - Postharvest costs ($/gram) $ 262,754